BioCentury
ARTICLE | Clinical News

Beclomethasone Spiros: Began Phase III testing

October 18, 1999 7:00 AM UTC

Dura Pharmaceuticals Inc. (DURA), San Diego, Calif. Product: Beclomethasone Spiros Business: Autoimmune/Inflammation, Pulmonary Therapeutic category: Immune suppression Target: Immune cells Descriptio...